The expression of DCAF8 and PAX8 in tumors illustrates patterns of significant downregulation (p = 0.0262) and upregulation (p = 0.00174) across cancer stages 1 and 3, respectively (Figure 7E). This evidence concerns the gene PAX8 and cancer.